Alstonia scholaris, commonly known as sapthaparna, has been used for centuries in Ayurvedic medicine for treatment of various disorders. The objective of this study was to investigate the possible chemopreventive and anti-oxidative properties of this medicinal plant on two-stage process of skin carcinogenesis induced by a single application of 7, 12-dimethyabenz(a)anthrecene (100 ìg/100 ìl acetone), and two weeks later, promoted by repeated application of croton oil (1% in acetone/thrice a week) till the end of the experiment (16 weeks) in Swiss albino mice. The tumor incidence, tumor yield, tumor burden and cumulative number of papillomas were found to be higher in the carcinogen treated control (without ASE treatment) as compared to experimental animals (ASE treated). Furthermore, a significant increase in reduced glutathione, superoxide dismutase and catalase but decrease in lipid peroxidation was measured in ASE administered experimental groups than the carcinogen treated control. The present study demonstrates the chemopreventive potential of Alstonia scholaris bark extract in DMBA-induced skin tumorigenesis in Swiss albino mice.
Introduction
Cancer is a leading cause of mortality worldwide. Cancer rates in India are lower than those seen in Western countries but are rising with increasing migration of rural population to the cities, increase in life expectancy, and changes in lifestyles. In India, rates for oral and esophageal cancers are some of the highest in the world. In contrast, the rates for colorectal, prostate, and lung cancers are one of the lowest. Skin is the most common site of malignancy and represents 55% all human cancers. Skin squamous cell carcinoma is increasing rapidly worldwide and ranks second in the prevalence of skin tumors. It accounts for 16% of all skin cancers. 1 Cancer chemoprevention is a means of controlling the occurrence of the disease by pharmacological intervention using chemical compounds. 2 Recent events suggest that new treatments for human diseases will be intimately connected to natural products. The use of medicinal plants in modern medicine for the prevention and treatment of cancer is an important aspect. For this reason, it is important to identify antitumor promoting agents present in medicinal plants commonly used by the human population that can inhibit the progression of cancer. 3, 4 Epidemiological studies have indicated that the risk of cancer may be modified by changes in dietary habits. 5 Humans ingest a large number of naturally occurring antimutagens and anticarcinogens in food, which may inhibit one or more stages of carcinogenesis. 3 Several studies have indicated that compounds with antioxidants or anti-inflammatory properties as well as certain phytochemicals can inhibit tumor initiation, promotion, and progression in experimental animal models. 6, 3, 7 The medicinal herb Alstonia scholaris (L) RBr (Apocynaceae) has been used in folk and traditional systems in India to treat several diseases. The ripe fruits of plants are used for treating syphilis, insanity, and epilepsy. It is also used as a tonic, antiperiodic, and antihelminthic. The milky juice of A scholaris has been applied to treat ulcers. The bark is the most extensively used part of this plant and is used in many herbal formulations. 8 It is a bitter tonic, alternative, and febrifuge and is reported to be useful in the treatment of malaria, diarrhea, and dysentery. [8] [9] [10] The species has also been reported to inhibit liver injuries induced by carbon tetrachloride, b-D-galactosamine, acetaminophen, and ethanol. 11 On the basis of the above-mentioned distinctive features of this plant, the present study has been focused on evaluating the possible chemoprotective potential of A scholaris against 7,12-dimethylbenz(a)anthracene-induced skin carcinogenesis in Swiss albino mice.
Materials and Methods

Animal Care and Handling
Random-bred male Swiss albino mice (6-7 weeks old and weighing 26.4 ± 0.23 g) were used for this study. These were maintained in the animal house at temperatures of 24°C ± 3°C and light conditions of 14 h light and 10 h of darkness. The animals were fed on standard mouse feed procured from Ashirwad Industries Ltd, Chandigarh, and water ad libitum. Six animals were housed in a polypropylene plastic cage containing sawdust (procured locally) as bedding material. Tetracycline water was given to them once in a fortnight to prevent infections. Animal care and handling were performed according to the guidelines set by the WHO, Geneva, Switzerland, and the INSA (Indian National Science Academy), New Delhi, India. The Departmental Animal Ethical Committee approved this study.
The dorsal skin of the animals in the interscapular area was clipped 3 days before the commencement of the experiment, and only those animals that showed no hair growth were considered for the study.
Chemicals
The carcinogen, 7,12-dimethylbenz(a)anthracene C (DMBA), and croton oil were procured from Sigma Chemicals Co, St Louis, MO. DMBA was dissolved in 100 mg/100 mL in acetone. Croton oil was mixed with acetone to provide a solution with 1% dilution.
Alstonia scholaris Extract Preparation
A scholaris was identified by a competent botanist in the herbarium of the Botany Department of the University of Rajasthan, Jaipur (Voucher No. RUBL19939). Fresh bark of A scholaris was collected, cleaned, shed dried, powdered, and extracted. The extract was prepared by refluxing with double distilled water (DDW) for 36 (3 × 12) h. The cool liquid extract was concentrated by evaporating its liquid contents so as to obtain it in powdered form. An approximate yield of 22% extract was obtained. The extract was resolved in DDW just before oral administration in mice. (Henceforth in this article, the extract of A scholaris bark will be referred to as ASE.)
Experimental Design
A total of 32 animals were used for the present experiment in the experimental groups (ie, groups III-VI). Besides this, 8 animals were selected for the vehicle control and drugtreated groups (ie, groups I and II). The experiments were conducted as follows:
Group I. These animals (n = 4) were given DDW orally, which was equivalent to the dose of ASE (100 mg/kg by weight), throughout the experiment and were the vehicletreated controls.
Group II. Animals in this group (n = 4) received only ASE (100 mg/kg by weight per day) throughout the experiment (ie, 16 weeks) and were the drug-treated control animals.
Group III. In this group of animals (n = 8), a single dose of DMBA (100 mg/100 mL in acetone) was applied topically over the shaved area of the skin. After 2 weeks, croton oil (1% in 100 mL of acetone) was applied 3 times a week until termination of the experiment (ie, 16 weeks). Mice in this group were given DDW orally equivalent to the dose of ASE (100 mg/kg by weight per day) throughout the experiment. This group was the carcinogen-treated controls.
Group IV. For these animals (n = 8), a single dose of DMBA (100 mg/100 mL in acetone) was applied topically over the shaved area of the skin; this was followed by repeated application of croton oil (1% in 100 mL of acetone thrice a week) till the end of the experiment as a promoter. These animals received aqueous ASE (100 mg/kg by weight per day) by oral gavage for 14 days (ie, 7 days before and 7 days after the DMBA application). They were the ASE-treated experimental-I group.
Group V. Animals in this group (n = 8) received ASE orally (100 mg/kg by weight per day) starting from the time of croton oil treatment, and this was continued till the end of the experiment (ie, 16 weeks). DMBA application was similar to that in group III. These were considered the ASE-treated experimental-II group.
Group VI. These animals (n = 8) were given ASE orally from the day of DMBA application as well as in the promotional stage. Croton oil treatment was given as in Group III. This was considered the ASE-treated experimental-III group.
During the 16 weeks of experiments, mice were observed weekly for the appearance of skin papillomas. The parameters that were taken into consideration are discussed below.
Morphological Analysis
Tumor incidence. This is the number of mice carrying at least 1 tumor expressed as percentage incidence.
Tumor yield. This refers to the total number of tumors per group and the mean number of tumors per mouse.
Cumulative number of papillomas. The total number of tumors that had appeared by the end of the experiment was considered the cumulative number of papillomas.
Average latent period. The lag between the application of the promoting agent and the appearance of 50% tumors was determined. The average latent period was calculated by multiplying the number of tumors appearing each week by the time in weeks after the application of the promoting agent and dividing the sum by the total number of tumors:
where f is the number of tumors appearing each week, x is the number of weeks, and n is the total number of tumors.
Biochemical Analysis
Biochemical analysis was performed in the above groups at the time of termination of the experiment (ie, after 16 weeks). The parameters that were assayed are described below.
Lipid peroxidation (LPO). The level of LPO in liver and blood was measured in terms of thiobarbituric acid reactive substances by the method of Okhawa et al. 12 Briefly, thiobarbituric acid (0.8%), sodium dodecyl sulfate (0.1%), and acetic acid (20%) were added to 100 mL of the tissue homogenate for 60 min, cooled, and extracted with N-butanolpyridine; the optical density of LPO was recorded at 532 nm. The content of LPO is expressed in nmol/mg.
Glutathione (GSH). The hepatic level of reduced GSH was estimated by the method of Moron et al. 13 The GSH content in the blood was measured spectrophotometrically using Ellman's reagent with 5,5'-dithiobis(2-nitrobenzoic acid; DTNB) as a coloring agent, according to the method of Beutlar et al. 14 The absorbance was recorded at 412 nm. The levels of GSH are expressed as nmol/mg of protein.
Catalase (CAT) assay. Catalase was assayed by Aebi's method. 15 It was estimated at 240 nm by monitoring the disappearance of H 2 O 2 . Superoxide dismutase (SOD) analysis. SOD was assayed by using the technique of Marklund and Marklund, 16 which involves inhibition of pyrogallol autooxidation at pH 8.0.
Statistical Analysis
Statistical significance of differences between the groups was determined by Student's t test.
Results
Morphological Analysis
The findings of the present study are shown in Figures 1 to 9 . No tumor was observed in animals in groups I and II. The administration of ASE orally in group II did not affect the body weight of the animals during the experimental period. Papillomas started appearing on the skin area from 5 weeks onward during exposure to the initiator and the promoter. The percentage inhibition of tumor multiplicity was reduced significantly in all the experimental groups (ie, groups IV and V) as compared with controls (ie, group III). Figure 1 demonstrates the cumulative number of papillomas, that is, the total number of tumors appearing by the end of the experiment. In group III (carcinogen-treated control) animals, treated with a single dose of DMBA and promoted by repeated application of croton oil 2 weeks later, the cumulative number of papillomas was recorded as 48. In the animals in group IV (experimental-I), receiving similar treatment of DMBA and croton oil while subjected to oral administration of ASE for 14 days (ie, 7 days before and 7 days after the DMBA application), the cumulative number of papillomas was recorded as 15. In group V (experimental-II) in which animals received ASE orally (100 mg/kg by weight per day) starting from the time of croton oil treatment and continuing until the end of the experiment (ie, 16 weeks), the cumulative number of papillomas was 21. In group VI (experimental-III), treated orally with ASE (from the day of DMBA application), the cumulative number of papillomas was recorded as 31. Figure 2 represents tumor weight after various treatments. In group III (carcinogen-treated controls), tumor weight was found to be 248.6 mg. In the animals in group IV (experimental-I), tumor weight was 68.4 mg. In group V (experimental-II), the Tumor yield, that is, average number of papillomas per mouse, is depicted in Figure 3 . In group III (carcinogen-treated control), tumor yield was found to be 5.78. In the animals of group IV (experimental-I), the same was recorded as 2.38. In group V (experimental-II), in which the mice were administered ASE orally for 14 weeks from the time of croton oil application, tumor yield was measured as 2.66. In group VI (experimental-III), treated orally with ASE (from the day of DMBA application), tumor yield was recorded as 4.98. Figure 4 demonstrates the tumor incidence (%), that is, the number of mice carrying at least 1 tumor. The group III (carcinogen-treated control) animals, treated with a single dose of DMBA and 2 weeks later promoted by repeated application of croton oil, had 89% tumor incidence. In the animals of group IV (experimental-I), tumor incidence was recorded as 41.33%, whereas in group V (experimental-II), it was measured as 53%. In group VI (experimental-III), treated orally with ASE (from the day of DMBA application), tumor incidence was recorded as 78.66%.
Average latent period, that is, the lag between the application of the promoting agent and the appearance of 50% of tumors, was determined as depicted in Figure 5 . In group III, it was 5 weeks. On the other hand, the latent period was as 11, 7, and 6 weeks in groups IV,V, and VI, respectively. A statistically significant difference was found between control and experimental groups with respect to the different parameters studied. All differences were not significant at the level P < .001. The significance levels were calculated as P < .05, .01, and .001.
Biochemical Analysis
Lipid peroxidation. A considerable elevation of LPO level was noted in the blood serum and liver of group III animals.
Whereas administration of ASE significantly (P < .001) reduced the level of LPO in all the ASE experimental groups (IV-VI) in comparison to the carcinogen controls (group III), no significant alteration in LPO level was observed in groups I and II as compared with group III (Figure 6 ).
Reduced glutathione. Treatment with A scholaris extract resulted in an enhanced level of the nonenzymatic antioxidant protein GSH in both the blood and liver of animals in groups IV to VI as compared with the carcinogen controls (group III). On the other hand, a significant decrease (P < .001) in the level of GSH was recorded in group III (carcinogen control) animals as compared with groups I and II (Figure 7) . Superoxide dismutase. SOD activity was increased significantly (P < .001) in the liver and skin of ASE-administered animals (groups IV-VI) as compared with the carcinogen controls (group III; Figure 8 ).
Catalase analysis. A significantly increased (P < .001) CAT activity was recorded in the liver of ASE-treated experimental animals (groups IV to VI) as compared with the carcinogen controls (group III; Figure 9 ). Discussion 7,12-Dimethylbenz(a)anthracene, a potent organ-specific carcinogen, is present in the environment as a product of incomplete combustion of complex hydrocarbons. DMBA can act either as a complete carcinogen or as an initiator of mouse skin carcinogenesis. 17 DMBA on metabolic activation produces diol-epoxide (ultimate carcinogen), which mediates the carcinogenic process by inducing chronic inflammation, overproduction of reactive oxygen species (ROS), and oxidative DNA damage. 18 However, organisms possess an array of sophisticated antioxidant defense mechanisms (enzymatic and nonenzymatic) to combat the deleterious effects of ROS-mediated oxidative stress. The enzymatic antioxidant defense system includes SOD, CAT, and glutathione peroxidase (GPx), whereas the nonenzymatic antioxidants include vitamins E, C, and reduced GSH. 19 Chemoprevention aims to halt or reverse the development and progression of precancerous cells through the use of noncytotoxic nutrients and/or pharmacological agents during the time period between tumor initiation and malignancy. 20 Cancer chemoprevention has become an integral area of cancer research as it provides a practical approach to identify the potential inhibitors of carcinogenesis and also affords opportunities to study the probable mechanism(s) of carcinogenesis. 4, 21 The present investigation was undertaken to evaluate the effect of natural agents that can act chemopreventively against cancer. Medicinal plants are an important source of diverse chemical compounds that have been used for the past several centuries in the treatment of cancer. About 25% of drugs in the modern pharmacopoeia are derived from plants, including several anticancer drugs currently in clinical use. 22 A scholaris is used as a tonic, antiperiodic, anthelminthic, stimulant, carminative, stomachic, and expectorant. 23, 24 The ripe fruits are used to treat insanity, which was earlier thought to be caused by epilepsy and syphilis. The most extensively used part of the plant is the bark, which is a component of many herbal formulations. The bark extract of the powdered stem bark is a bitter tonic and febrifuge, useful for the treatment of malaria, diarrhea, and dysentery. 23 The bark decoction is also used to treat asthma, hypertension, lung cancer, and pneumonia. 24 It has been reported that A scholaris bark contains the alkaloids alstonidine, alstonin, alstovenine, chlorogenic acid, chlorogenine, ditain, ditaine, echicaoutchin, echicerin, echiretin, echitamine, echaitein, echitinin, echitin, porphyrine, porphyrosine, and reserpine. 5, 25, 26 Antioxidants act synergistically to counteract the deleterious effects of free radical-mediated LPO. SOD and CAT protect cells by catalyzing the harmful ROS such as O 2 -(SOD) and H 2 O 2 (CAT). Lowered activities of these enzymes were reported in several cancerous conditions, including skin carcinogenesis. [27] [28] [29] Our results are in line with these findings.
The present study clearly demonstrates that extracts of A scholaris can induce reversal of altered enzyme activities, although the nature of the CAT enzyme during DMBAinduced carcinogenesis and following treatment is not quite clear at this stage. However, it is evident that the modulation of the enzyme activity is accompanied by a reduction in LPO, a process known to generate ROS that is associated with tissue injury and damage of several macromolecules. 10, 30 Lowered enzymatic and nonenzymatic antioxidants observed in the present study confirm the state of oxidative stress in DMBA-induced mice skin carcinogenesis.
LPO is regarded as one of the basic mechanisms of cellular damage caused by free radicals. DMBA is a very effective carcinogen in interacting with membrane lipids and leads to increased lipid peroxides accompanied by compromised antioxidant defenses and consequently inducing free radical formation. 31 An increase in lipid peroxide indicates serious damage to cell membranes, inhibition of several enzymes and cellular function, and cell death. 32, 33 Oral administration of ASE restored the status of LPO in DMBA-treated animals. The same has been reported with Emblica officinalis extract administration, 29 and Tinospora administration. 27 Glutathione acts as a most important antioxidant in living systems because it is a remover of H 2 O 2 lipid peroxides and their products like 4-hydroxinental. 34 In the present study, a decrease in the level of GSH has been observed, and this may be because of enhanced oxidative damage, enhanced use of GSH by the enzyme GPx, and a reduction in the activities of the GSH-synthesizing enzymes such as glucose-6-phosphatedehydrogenase and GPx, which neutralize the hydroxyl radical and singlet oxygen. Because it is present in high concentration in the cells, it protects cells from free radical damage. 35 Similarly Rosmarinus extract also showed elevation of GSH through the modulation of cellular oxidant levels. 29 
Conclusion
The present study demonstrated the chemopreventive and antioxidant functions of ASE in DMBA-induced skin carcinogenesis. Further studies are needed to isolate and characterize the bioactive constituents from the bark of A scholaris.
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